RS Research Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series B
  • (Upcoming)

  • Investors
  • 7

RS Research General Information

Description

Developer of nanomedicine technologies intended to enable targeted chemotherapy for cancer treatment. The company offers polymer-based drug conjugates and nanocarrier drug-delivery technology with targeted delivery capabilities, enabling medical researchers and oncology healthcare providers to study and administer chemotherapy with controlled drug targeting.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Teknopark Istanbul
  • Sanayi Mahallesi Teknopark Boulevard. Number:1/2A-401
  • 34912 Istanbul
  • Turkey
+90 0535
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Teknopark Istanbul
  • Sanayi Mahallesi Teknopark Boulevard. Number:1/2A-401
  • 34912 Istanbul
  • Turkey
+90 0535

RS Research Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RS Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) Upcoming Clinical Trials - Phase 1
7. Grant 31-Mar-2024 Completed Clinical Trials - Phase 1
6. Accelerator/Incubator 05-Mar-2024 Completed Clinical Trials - Phase 1
5. Secondary Transaction - Private 13-Jun-2023 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series A) 23-Dec-2021 Completed Clinical Trials - Phase 1
3. Early Stage VC 29-Dec-2017 Completed Pre-Clinical Trials
2. Seed Round 26-Sep-2017 $1.31M $1.31M Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view RS Research’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RS Research Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RS Research Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
Turcorn 100 Accelerator/Incubator
Eczacıbaşı Momentum Corporate Venture Capital Minority
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret Corporation Minority
İstanbul Portföy Yönetimi Asset Manager Minority
You’re viewing 5 of 7 investors. Get the full list »

RS Research FAQs

  • When was RS Research founded?

    RS Research was founded in 2015.

  • Where is RS Research headquartered?

    RS Research is headquartered in Istanbul, Turkey.

  • What is the size of RS Research?

    RS Research has 18 total employees.

  • What industry is RS Research in?

    RS Research’s primary industry is Drug Discovery.

  • Is RS Research a private or public company?

    RS Research is a Private company.

  • What is RS Research’s current revenue?

    The current revenue for RS Research is .

  • How much funding has RS Research raised over time?

    RS Research has raised $14.4M.

  • Who are RS Research’s investors?

    European Innovation Council, Turcorn 100, Eczacıbaşı Momentum, Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret, and İstanbul Portföy Yönetimi are 5 of 7 investors who have invested in RS Research.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process